Sequoia Financial Advisors LLC Buys 1,171 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Sequoia Financial Advisors LLC boosted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 67.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,898 shares of the biotechnology company’s stock after purchasing an additional 1,171 shares during the period. Sequoia Financial Advisors LLC’s holdings in Axon Enterprise were worth $1,722,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Asset Dedication LLC lifted its stake in Axon Enterprise by 11.3% in the 4th quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after purchasing an additional 18 shares during the last quarter. Bleakley Financial Group LLC raised its stake in shares of Axon Enterprise by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after acquiring an additional 20 shares during the last quarter. Venturi Wealth Management LLC raised its stake in shares of Axon Enterprise by 2.7% during the fourth quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after acquiring an additional 21 shares during the last quarter. Insigneo Advisory Services LLC raised its stake in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after acquiring an additional 22 shares during the last quarter. Finally, Menard Financial Group LLC raised its stake in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after acquiring an additional 24 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on AXON. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research note on Monday. Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Insiders Place Their Bets

In other news, President Joshua Isner sold 1,291 shares of Axon Enterprise stock in a transaction dated Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the transaction, the president now directly owns 181,892 shares in the company, valued at $116,852,877.56. This trade represents a 0.70 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now owns 24,259 shares of the company’s stock, valued at $15,518,239.71. This represents a 3.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 5,146 shares of company stock worth $3,262,847. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Trading Up 4.1 %

NASDAQ:AXON opened at $556.26 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $42.62 billion, a price-to-earnings ratio of 143.74, a PEG ratio of 5.17 and a beta of 1.12. The firm has a fifty day simple moving average of $594.32 and a two-hundred day simple moving average of $532.91. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.